February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Delineating the Cause of Memory Impairment

6th Congress of the European Academy of Neurology 2020

Welcome and Introduction
to Our Patient: A Case Study for Discussion

Panel chair Giovanni Frisoni, MD, PhD, introduces the symposium’s topics, objectives, and expert panelists before briefly discussing the burden and clinical presentation of Alzheimer’s disease. He then introduces a patient case study, which describes the journey of a patient with the early stages of Alzheimer’s disease, throughout the symposia, from initial presentation to receiving a diagnosis.

Key Learning Objectives for Biogen’s EAN 2020 Symposium:

  • Understand the value of an early diagnosis of Alzheimer’s disease
  • Gain insights on how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an accurate and timely diagnosis of mild cognitive impairment due to Alzheimer’s disease
  • Assess the current healthcare system readiness for a paradigm shift to early diagnosis

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.